Navigation Links
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Date:6/12/2013

2013, and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product.  Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures.   Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market.  Our business may be impacted by government investigations, litigation and product liability claims.  If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
2. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
3. Amgen And Astellas Announce Japan Alliance
4. Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
7. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
8. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
9. Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
10. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
11. Amgen Announces Webcast of 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)...  Now available for sale, The Armor1 Ankle Roll Guard is ... sprains by cushioning the ankle from an inversion or ... outside of any shoe type and allows the user ... protection against sprains. With customers in physical therapy, podiatry, ...
(Date:1/23/2015)... VEGAS , Jan. 23, 2015 Cord Blood America, ... ) ("CBAI" or the "Company")  filed a Preliminary Proxy Statement, ... www.sec.gov ) today, and provides an update for shareholders detailing ... shares is requested. Dear Shareholders, As ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... 2011 GeneTex, a leading manufacturer of high ... specials on products from their large catalog containing ... damage antibodies, proteins, peptides, and research reagents.  Plus, ... quantitative measurements of proteins including cytokines, interleukins, growth ...
... Aug. 23, 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) is ... result in the reduction of more than $620,000 in debt ... agreement and new consulting agreement will result in a reduction ... Endoscopy posted its financial statements for period ended June 30, ...
Cached Medicine Technology:There's an Ab for That! GeneTex Offers One of the Largest Catalogs of Antibodies 2Solos Endoscopy to Reduce Debt by Over $620,000 2
(Date:1/22/2015)... 2015 Deer Path of Huntley -- ... Day Happy Hour from 3 p.m. to 4 p.m. on Feb. ... in Huntley, Illinois, serves adults with physical disabilities between the ages ... Valentine's Day treats, games and sweetheart-themed karaoke. , For more information ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located in ... number one best large hotel for families in the United ... annual Travelers’ Choice Awards. , TripAdvisor represents the world’s ... to millions of unbiased and honest traveler reviews. The best ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many ... it on Facebook, Twitter, and Pinterest. The fans will have ... a lottery every week. , Moreover, the company has extended ... Angelweddingdress homepage for more information. , Angelweddingdress ...
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... make a dramatic difference in the management of patients with ... a new study finds. // ,The study, of ... 35% of patients, said Philip W.P. Bearcroft, MD, of Cambridge ... more significant is the fact that before an MRI was ...
... the U.S., the poorer their mental health becomes.// That’s ... prevalence of psychiatric disorders among Black individuals in the ... of the American Journal of Public Health. ,David ... of Society, Human Development and Health at the Harvard ...
... from the European Molecular Biology Laboratory's (EMBL) Mouse Biology ... Olavide in Sevilla,// Spain, now for the first time ... The study, which appears in the current issue of ... involved in learning and singled out the signaling pathway ...
... genetics and law experts at the Sandra Day O’Connor ... that could dramatically// hasten the development of personalized medicine. ... American Medical Association Journal, side effects from prescription drugs ... number of these deaths could be prevented by the ...
... as Hispanic and white women in two separate clinical ... be diagnosed// with later-stage cancer and to have more-aggressive ... the study, lead researcher Wendy Woodward of the University ... examined 2,140 women participating in two clinical trials of ...
... the first place among states and union territories to enforce ... find any genetic disorder// that could lead to disabilities. ... screening of all children would be done to check any ... introduce screening shortly. ,While poor people would be ...
Cached Medicine News:Health News:Researchers Investigate Molecular Basis of Memory 2Health News:More Americans Die Due To Side Effects From Prescription Drugs Every Year: Report 2Health News:More Americans Die Due To Side Effects From Prescription Drugs Every Year: Report 3
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
... The Carpal Solution offers relief from ... It is different from other over-the-counter CTS ... brace. Worn during sleep, the Carpal Solution ... the Carpal Tunnel and eliminates hand pain, ...
... is a manual Modified Westergren system ... rate (ESR) of whole blood in ... Tubes. The rack will accommodate up ... Manual Rack exhibits >96% correlation to ...
... BC is an assayed control for immunophenotyping ... Plus BC determines the accuracy and reproducibility ... process of immunophenotyping, including red blood cell ... leukocytes include: T lymphocytes, B lymphocytes, granulocytes, ...
Medicine Products: